AdAlta secures key manufacturing agreements for AD-214
AdAlta secures key manufacturing agreements for AD-214 Please click here for an ASX announcement relating to the execution of key manufacturing agreements for AD-214
Walter and Eliza Hall Institute news: Structure of protein pair provides blueprint for future drugs
Walter and Eliza Hall Institute researchers have visualised for the first time how the protein SOCS1 ‘switches off’ cell signalling to dampen immune responses and block cancer growth. The atomic-level structure of SOCS1 binding to its partner protein…
Women Leading World-Class Health Innovation in Melbourne
Victoria grows globally competitive innovation-intensive companies. Innovation is a people-driven process that thrives on diverse thinking and views. Now that business is embracing the performance-based argument, successful women in and those aspiring towards leadership roles need recognition to…
Australia is backing health innovation industries to build future economy
Announced in the federal budget last night, the 21st century National Medical Industry Growth Plan will deliver $1.3 billion to support Australia as a global health innovation leader in medical technology, biotechnology and pharmaceuticals while improving health outcomes for…
New BioMelbourne Network Board Appointment – David Herd
The BioMelbourne Network Board was delighted to welcome David Herd as new Board Director at the most recent board meeting. “BioMelbourne is a very active and positive contributor to shaping many aspects of our Industry and I am…
BioMelbourne Network gives State Budget 6/10 for the health innovation industry
BioMelbourne Network CEO Dr Krystal Evans welcomes the State Government of Victoria’s Budget yesterday, noting the significant investment in digital infrastructure, the Heart Hospital and the ongoing operational support for the Melbourne Biomedical Precinct. However, these initiatives are…
BioMelbourne Network Policy Principles – 2018 State Election
May 2018 The biotechnology, medical technology and pharmaceutical sector in Victoria is vibrant and growing but yet to reach its full potential contribution to the Victorian economy. Historical support from governments has allowed the sector to grow, now…
AusBiotech announces leadership changes
Mr Glenn Cross retires as AusBiotech’s CEO, and Ms Lorraine Chiroiu appointed as new CEO effective early July 2018 Mr Glenn Cross retirement AusBiotech Chairman, Julie Phillips, has tonight announced that Mr Glenn Cross has decided to retire…
Future Plans Announced for Digital Health CRC
A $200+ million opportunity to transform health delivery: improving health outcomes; reducing waste in the health system; building businesses and jobs. The new Digital Health CRC (Cooperative Research Centre) will invest over $200 million to develop and test…
$10m in funding awarded to 11 projects to boost health innovation
MTPConnect – the Australian Government’s Medical Technology, Biotechnology, and Pharmaceutical (MTP) Industry Growth Centre – and the Minister for Health, the Hon Greg Hunt MP, today announced the first 11 recipients of $10 million investment from the Australian…
Bioforum Data Focused CRO Opens New Melbourne Office
Company provides local services for companies running R&D activities in Australia Bioforum – the Data Focused CRO and the leading Medidata partner in Israel, servicing research and academic institutes, pharma companies, CROs and startups locally and globally for…
Prota Therapeutics partners with world-leading bioscience company, Chr. Hansen
Prota Therapeutics partners with leading global bioscience company, Chr. Hansen, to progress the development of oral immunotherapies to treat food allergies. The partnership will assess the world’s best documented probiotic strain LGG® in a Phase III clinical trial…
